• Hernia Mesh Lawyers: In their ongoing mission to help people injured by dangerous drugs and devices the Pradaxa Helpline has launched a Hernia Mesh Hotline. More and more people have been reporting complications from a hernia mesh surgery. ...
  • Texas Pradaxa Lawyer: Get Your Texas Pradaxa  Lawyer Texas Pradaxa Lawyer  Network has Texas Pradaxa  lawyers ready to help you if you have been injured by Pradaxa extensive bleeding in: Dallas, Houston, Abilene, Amarillo, Austin, Arlington,...
  • Xarelto Lawsuit Helpline | Xarelto Lawyers: Xarelto Lawsuit Helpline Get An Xarelto Extensive Bleeding Lawyer If you or a loved one took Xarelto for prevention of blood clots and pulmonary embolisms and this resulted in severe injury or death  contact  Xarelto L...

Louisiana Pradaxa lawsuits Filed, Louisiana Pradaxa Lawyers, extensive Bleeding from Pradaxa

Written by Xarelto Helpline on . Posted in Louisiana

Dangerous Drug Pradaxa Death Case Filed in Louisiana, Louisaina Pradaxa helpline and Lousiana Pradaxa lawyers concerned about seniors with fatalities for Pradaxa. If you are having complications from Pradaxa or a loved one has died in Louisiana from extensive bleeding from Pradaxa call the Louisiana  Pradaxa Helpline and speak to  medical social worker about Pradaxa. Pradaxa Helpline lawyers are available to explain the Louisiana Pradaxa  lawsuits. A Geriatric  Medical social worker is available to help you in Alexandria, Baton Rouge, Houma,Lafayette, Lake Charles,Monroe, New Orleans, Shreveport and all of Louisiana if you are a caregiver with questions about the Pradaxa lawsuits.

The first three dangerous drug litigation cases involving the drug Pradaxa were filed in federal court this week involving instances of injury and death. Case filed in Louisiana, Tennessee and Kentucky will likely represent a larger class of individuals if there are continued reports of injury and death associated with the drug Pradaxa.

Pradaxa, produced by Boehringer Ingleheim, is indicated to reduce the risk of stroke in patients suffering from AFib or atrial fibrillation. Patients suffering from atrial fibrillation normally require a blood-thinning agent such as warfarin, which for over 60 years was the only Food and Drug Administration (FDA) approved medicine until Pradaxa entered the market. However, recent reports of fatal bleeding in patients taking the drug Pradaxa have prompted the FDA to require a minor label change.

In November 2011, there were over 260 confirmed fatalities with patients taking Pradaxa and suffering from internal hemorrhaging. The number of side effects and the amount of deaths associated with the prescription medication has prompted labeling updates in the United States, Japan, Australia, and Europe. In January 2012, the FDA encouraged Boehringer Ingelheim to added additional information to their package insert; however, the package still does not carry a "black box warning" and there has been no FDA recall to date.

Tags: , , , , , , , , , , , , , ,